Posts

Showing posts from February, 2022

The antibody contract manufacturing market, predicts Roots Analysis.

  The benefits of engaging a CMO or CDMO for antibody development and production extend beyond fulfilling the needs of small companies; access to new technologies and operational flexibility are attractive attributes to larger players as well   Roots Analysis is pleased to announce the publication of its recent study, titled, “ Antibody Contract Manufacturing Market , 2020-2030 ” report to its list of offerings.   To request a sample copy / brochure of this report, please visit this – https://www.rootsanalysis.com/reports/295/request-sample.html               The report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of antibodies. The study also features a detailed analysis of key drivers and trends related to this evolving domain. In addition to other elements, the study includes: §   A detailed review of the...